Podcasts about vicarious surgical

Follow me @samirkaji for my thoughts on the venture market, with a focus on the continued evolution of the VC landscape.We have a conversation with Samir Kaul from Khosla Ventures. Founded in 2004, Khosla is one of the largest and most well-known venture capital firms in the world and led by legendary investor and entrepreneur Vinod Khosla. The firm is known for investing in companies that are solving very large and complex problems. The firm currently has over $15B in AUM investing in companies such as Square, Doordash, Stripe, OpenAI, and Impossible Foods.During the episode, we covered investing across cycles, the market insanity we saw pre-2022, and how they approach both building a firm and investing. Note: We recorded this prior to the news that Keith Rabois was rejoining the firm, hence no mention of it during the discussion.About Samir Kaul:Samir Kaul is a Founding Partner and Managing Director at Khosla Ventures, and he specializes in investments across health, sustainability, food, and advanced technology sectors. His notable investments leading to successful exits through IPOs or acquisitions include companies like Vicarious Surgical, View, Guardant Health, Nutanix, Oscar, Quantumscape, Granular, SLD, NanoH2O, Iora Health, and Raxium. Additionally, he has played a pivotal role in investments in transformative startups such as Impossible Foods, Mojo Vision, Primer, and many others, demonstrating a keen eye for identifying and nurturing groundbreaking technologies and business models.Before joining Khosla Ventures, Samir's career was marked by significant achievements in biotechnology and venture capital at Flagship Ventures and the Institute for Genomic Research, where he contributed to pioneering efforts in genomics and biotech startups like Helicos BioSciences and Codon Devices. His work in sequencing the Arabidopsis genome set new standards for efficiency and impact in the field of genomics. Beyond his professional endeavors, Samir is deeply committed to philanthropy, serving on the boards of the Tipping Point Community, UCSF Benioff Children's Hospital, and the US Ski and Snowboard Association, showcasing his dedication to societal betterment and healthcare.In this episode, we discuss:(01:45) Samir's career path to venture(05:15) Traits of Successful Entrepreneurs(06:04) Building Long-term Companies(08:49) Venture Capital's Role Beyond Funding(12:13) Evolution of Venture Capital(16:15) AI and Tech Super Cycles(22:24) Learning from Past Mistakes(28:03) Investing in High Conviction Trends(32:33) Firm Culture and Decision Making(37:17) Hiring and Building a VC Team(39:12) Advice to Younger SelfI'd love to know what you took away from this conversation with Samir. Follow me @SamirKaji and give me your insights and questions with the hashtag #ventureunlocked. If you'd like to be considered as a guest or have someone you'd like to hear from (GP or LP), drop me a direct message on Twitter.Podcast Production support provided by Agent Bee  This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ventureunlocked.substack.com

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, January 30, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. RenovoRX closed a $6.1 million private placement. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what RenovoRX is developing and how it wants to spend the funds.  Vicarious Surgical has picked a former Olympus executive as president. Find out who is taking on this role and some of their career history.  ReWalk Robotics rebranded to 'Lifeward' as its portfolio continues to expand. Whooley shares the reason behind the rebrand and what executives are thinking. Globus Medical is laying off 157 employees at the former NuVasive headquarters. Hear more about the reason behind the layoffs and which departments are affected. Philips has discontinued certain CPAP product lines after the ongoing recall saga. The Fast Five hosts talk about the consent decree and how the company came to this decision. BONUS: Read the top IVD and diabetes stories of 2023.

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Philipp Vetter und Holger Zschäpitz über KI-Einsparungen bei Alphabet, Merger-Fantasien in der amerikanischen Unterhaltungsbranche und die Folgen des Chefwechsels bei BASF. Außerdem geht es um ProSiebenSat 1, Warner Bros Discovery, Paramount Global, United Internet, 1&1, Ionos, DHL, Fedex, Orsted, Siemens Energy, Vestas, Domino's Pizza, Meta, Micron Technologies, Ulta Beauty, Chevron, Coca-Cola, Gitlab, Merck, Visa, Vicarious Surgical, iShares ESG Aware MSCI USA ETF (WKN: A2DKNE), PDR S&P 500 ETF Trust (WKN: 898706), Vanguard S&P 500 ETF (WKN: A1W6M5), iShares Core S&P 500 ETF (WKN: A0YEDG), ProShares UltraPro QQQ (WKN: A1CXPT), Direxion Daily Semiconductors Bull 3x Shares (WKN: A1C1G7), iShares MSCI Emerging Markets ETF (WKN: 469253), iShares MSCI Emerging Markets ex China ETF (WKN: A2DVUJ), Invesco Nasdaq 100 ETF (WKN: 801498), Xtrackers Artificial Intelligence & Big Data UCITS ETF (WKN: A2N6LC), Roundhill Generative AI & Technology ETF (ISIN: US88636J6001). Wir freuen uns über Feedback an aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hier findet ihr alle AAA-Bonus-Episoden bei WELT – dazu den AAA-Newsletter und noch weitere WELTplus-Inhalte: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

On this episode of the podcast, we check in with Adam Sachs, cofounder and CEO of Vicarious surgical robots. Adam comes back to the show with an update on the long journey to market for surgical robots. Adam last joined us in Episode 56, back in September 2021 when Vicarious first launched the Vicarious Surgical robot into pilot implementations. The Vicarious Surgical robot utilizes a single port requiring a 1.5 cm incision — smaller than the size of a dime — for the insertion of the camera and two robotic instruments, transporting surgeons to a new world of visibility and maneuverability. To learn more about Vicarious Surgical goto: www.vicarioussurgical.com Also on this episode, cohosts Steve Crowe and Mike Oitzman discuss the recent news from General Motors, owner of Cruise about the future of Cruise robotaxi service, and the other major news about the EU response to the Amazon iRobot proposed merger. If you like the show, please subscribe and tell a friend about it, this helps us grow our audience. Thanks.

Day Zero Diagnostics and Oxford Nanopore today announced a collaboration to develop a solution for diagnosing bloodstream infections. Fast Five hosts Jim Hammerand and Sean Whooley dive into the details of the partnership. Asensus Surgical inked a manufacturing deal with Flex for services around its next-generation surgical robot platform. Listen for the details of the partnership and some other news about Asensus' other surgical robotic offerings. Johnson & Johnson MedTech followed up its Ottava news from last week with a regulatory win for a different surgical robot in China. The hosts unpack what the company's Monarch robot does and why its latest milestone is significant. The FDA says the recall of stolen, defective Medtronic laryngoscopes is Class I, the most serious kind. Hear all the details of this recall, including how third parties are attempting to profit from these stolen devices. Vicarious Surgical is cutting its headcount again as it pushed back the development timeline for its surgical robotic platform. The hosts break down the updated timeline, the ramifications of the layoffs and what analysts have to say on the matter. Check out the show notes at MassDevice.com/podcast.

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, September 26, 2023. Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast. A new study has backed Attune Medical's esophagus-protecting device. Fast Five hosts Sean Whooley and Danielle Kirsh explain the technology and the regulatory backing behind it. Surgical robotics are in the news again. USMI is set to debut its Canady surgical robot. Find out what the robot does and what executives are saying. Dexcom has signed a partnership with RxFood to focus on AI-based nutrition and glucose monitoring for diabetes management. Whooley explains the goal behind the partnership and how they plan to accomplish their goal. Vicarious Surgical is facing an NYSE delisting. The Fast Five hosts detail what the delisting notice said and what steps Vicarious can take to rectify the problem. Enovis this week announced plans to acquire LimaCorporate for more than $840 million. Hear what LimaCorporate does and how this acquisition supplements Enovis' portfolio.

Movano is submitting its smart ring for pulse oximetry to the FDA. Fast Five hosts Danielle Kirsh and Sean Whooley discuss the clinical performance of the smart ring and how it could be a competitive differentiator. Henry Schein is making a homecare play with the acquisition of Shield Healthcare. Henry Schein officials see the move as bolstering the company's commitment to facilitating a continuum-of-care delivery model. Hear how the acquisition fits into the company's strategic plan and what types of products will be added to Henry Schein's portfolio. Vicarious Surgical announced that it priced an underwritten public offering worth approximately $45 million in proceeds. Find out what is included in the offering, when it closes and some of Vicarious Surgical's other positive news.  Earnings season continues, and today's earnings story comes with an announcement of an executive shuffle. Smith+Nephew performed better than analyst expectations in the last quarter, but a vital executive announced plans to step down in 2024. Find out who is leaving the company and how Smith+Nephew's financial performance played out. Outset Medical paused shipments for its TabloCart with Prefiltration, an accessory for Tablo. The company said the shipment hold is pending FDA clearance, for which Outset plans to submit later this month. Whooley explains how this pause might affect the company's operations and financial results.  Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

https://youtu.be/p6UaNCMVwn0Matt has a fun conversation with Adam Sachs, the CEO and co-founder of Vicarious Surgical, who is developing a tiny, surgical robot that could radically change how surgery is performed. YouTube version of the podcast: https://www.youtube.com/stilltbdpodcastGet in touch: https://undecidedmf.com/podcast-feedbackSupport the show: https://pod.fan/still-to-be-determinedFollow us on Twitter: @stilltbdfm @byseanferrell @mattferrell or @undecidedmfUndecided with Matt Ferrell: https://www.youtube.com/undecidedmf ★ Support this podcast ★

Abbott recently released significant data backing the use of its Aveir dual-chamber leadless pacemaker. This data provides valuable insights into the device's performance, efficacy, and safety. Fast Five hosts Sean Whooley and Danielle Kirsh dive into the details of the study, examining the key findings and their implications for patients who may benefit from this advanced pacemaker technology. Moving on to Boston Scientific, which has shared positive data on two of its notable devices: Farapulse and Watchman FLX. The data supporting Farapulse demonstrates its potential in treating specific cardiac conditions, and the positive data for Watchman FLX highlights its effectiveness as a left atrial appendage closure device. Whooley explores these findings in detail, discussing how they contribute to the evolving landscape of cardiovascular care. A recent study from Philips suggests that artificial intelligence could predict ventricular tachycardia or arrhythmia. The study showcases the potential of AI algorithms to analyze complex patient data and provide early detection and intervention for this condition. Kirsh and Whooley examine the study methodology, discuss the implications of integrating AI into cardiac care, and explore the future possibilities it holds for improving patient outcomes. Vicarious Surgical has promoted John Mazzola to the position of chief operating officer. Mazzola's experience and contributions to the company have been instrumental in its growth and success. As COO, he will play a role in overseeing and optimizing the company's operations, driving innovation, and further advancing its surgical robotic platform. Whooley takes a closer look at Mazzola's background, the significance of this promotion, and the strategic direction of Vicarious Surgical moving forward. The Fast Five hosts share positive data from Medtronic's Harmony transcatheter pulmonary valve. The positive data from their recent study demonstrates the effectiveness and durability of this innovative device in treating patients with congenital heart defects. We'll explore the purpose of the study, the implications of the positive results, and how the Harmony valve offers a minimally invasive solution with improved outcomes for patients in need. Check out the show notes at MassDevice.com/podcast.

Vicarious Surgical aims to disrupt the surgical robotic market by streamlining its robotic system to provide the necessary tools for a range of medical procedures, all within a single incision that is less than two centimeters, Cofounder and CEO Adam Sachs explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Sachs sits down with BI analyst Matt Henriksson for an in-depth interview to discuss recent developments in robotic surgery, the company's upcoming US launch and the Hollywood classic film Fantastic Voyage.See omnystudio.com/listener for privacy information.

Um pequeno robô criado pela Vicarious Surgical é introduzido no corpo dos pacientes para tornar as cirurgias abdominais mais rápidas e seguras. Os médicos conseguem ter uma visão de 360 graus através da câmara do robô e de 56 sensores.

Um pequeno robô criado pela Vicarious Surgical é introduzido no corpo dos pacientes para tornar as cirurgias abdominais mais rápidas e seguras. Os médicos conseguem ter uma visão de 360 graus através da câmara do robô e de 56 sensores.Controlado pelos cirurgiões, o robô começa por fazer uma pequena incisão de apenas 1 centímetro e meio e, depois de entrar no corpo, tem como grande vantagem conseguir mover-se em todas as direções.Saiba mais sobre inovação e nova economia em supertoast.pt. 

Um pequeno robô criado pela Vicarious Surgical é introduzido no corpo dos pacientes para tornar as cirurgias abdominais mais rápidas e seguras. Os médicos conseguem ter uma visão de 360 graus através da câmara do robô e de 56 sensores.

In the third episode of the “Innovations in Surgery” series, Behind the Knife's surgery education fellow, Dan Scheese, sits down with Adam Sachs and Dr. Igor Belyansky to discuss the current state and future of surgical robotics. They discuss the start up of Vicarious Surgical and how they are working to improve the current state of surgical robotics with their innovative ideas.  Link for the Vicarious Surgical website which includes a short video demonstration of their single port design: https://www. vicarioussurgical.com/ Adam Sachs is the CEO and Co-founder of Vicarious surgical, a surgical robotics company founded in 2014. As an MIT trained roboticist, Adam has combined his passion for robots with this passion for helping patients and enhancing the work environment for surgeons through the development of proprietary surgical robotics.  Dr. Igor Belyanksy, an internationally-recognized expert in the field of abdominal wall reconstruction and complex laparoscopic and robotic hernia repair. Dr. Belyansky has earned his medical degree from Virginia Commonwealth University, completed his residency at MedStar Union Memorial Hospital, and completed a minimally invasive fellowship at Carolinas Medical Center. Dr. Belyanksy is currently the Medical Director of Anne Arundel Medical Center in Annapolis Maryland. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other Innovations in Surgery episodes here: https://behindtheknife.org/podcast-series/innovations-in-surgery/

In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers. We've got some highs – robots, diabetes – and some lows – Supply Chain, CPAP machines – and a whole lot of interesting things right in between. All an all, we're bullish on what's to come in 2023! And we only mentioned Covid-19 once. Companies mention include Abbott, Abiomed, Ambu, Becton Dickinson, Boston Scientific, CMR Surgical, Dexcom, Endiatx, embecta, Intuitive, Johnson & Johnson Medtech, Medtronic, Neuralink, Philips, Senseonics, Stryker, Synchron, Vicarious Surgical, Zimmer Biomet, ZimVie, and many more. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

In this week's episode, we'll talk with leaders from Zimmer Biomet and Vicarious Surgical about the new partners they've entered into with national hospital companies in a bid to further their digital and robotics surgery offerings. Guests include Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet, and Adam Sachs, co-founder and CEO of Vicarious Surgical. You'll get great background on both companies. One note: Tom Salemi interviewed Sachs during a DeviceTalks Tuesday Webinar. So if you'd rather watch the interview go to DeviceTalks.com where you can find the discussion – complete with video and PowerPoint presentation – available for free. Thanks to Cirtronics for sponsoring! Chris Newmarker, executive editor of life sciences, also returns with his Newmarker's Newsmakers – Stryker, Smith + Nephew, Medtronic, Johnson & Johnson, and Philips. Thanks for listening to the DeviceTalks Weekly Podcast.

In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current labor market. First, we connect with Joe McClung, president of Floodgate Medical, an executive search firm focused on the medical device industry, for an overview of the current market and some tips for job seekers. (Floodgate also sponsored this episode.) Next, Emma Plouffe, vice president of people and culture at Vicarious Surgical, tells us some of the tools she's using to find talent for the fast-growing surgical robotics company. Then, we end the episode connecting with Elizabeth Steele, vice president of Microspec Corp., a contract manufacturing business that's making a bold move to find and retain new employees. Of course, Chris Newmarker, executive editor of MassDevice, brings his Newmarkers Newsmakers – BD, GE Healthcare, LiveCor and Philips Respironics. Please subscribe on all major podcast players. Thanks for listening to DeviceTalks Weekly.

Amy and Julie sit down with Adam Sachs, CEO of Vicarious Surgical to find out how the company is going against an industry behemoth to achieve improved patient outcomes. Important Links: Vicarious Surgical: https://www.vicarioussurgical.com/  LinkedIn: https://www.linkedin.com/in/adamdsachs/  Twitter: https://twitter.com/adamsachsVS Learn more about your ad choices. Visit megaphone.fm/adchoices

Investment in robotics is picking up, as companies are finding opportunities to deploy AI-powered robots into new applications. In this exclusive interview, Brian Gahsman -- the Chief Investment Officer of the Contego Capital Groups and the Portfolio Manager of the AlphaCentric Robotics and Automation Fund (GNXIX) -- and his colleague Jin Kwon describe how robots are being used to improve global supply chain bottlenecks, to improve the efficiency of e-commerce logistics, and to improve the patient outcomes of surgeries. Publicly-traded companies mentioned in this interview include Fanuc, GXO Logistics, XPO Logistics, Apple, Procept Biorobotics, Vicarious Surgical, Medtronic, and Stereotaxis. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education: https://www.7investing.com Join the 7investing Community Forum: https://discord.gg/6YvazDf9sw Follow us: ► https://www.facebook.com/7investing ► https://twitter.com/7investing ► https://instagram.com/7investing --- Send in a voice message: https://anchor.fm/7investing/message Support this podcast: https://anchor.fm/7investing/support

In this episode, we'll dive deep into the Heart Failure business at Abbott. First we'll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers. This podcast is sponsored by KNF. Then, we'll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition. Dr. Kormos also shares the most gratifying part of his job. The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet. Happy New Year!!! We'll see you in 2022. LIKE! FOLLOW! SUBSCRIBE!

Host Dr. Nick van Terheyden, aka Dr. Nick, goes on a Fantastic Voyage for Surgery with Adam Sachs, CEO of Vicarious Surgical. Dr. Nick and Adam cover robotics that advance capabilities to place the surgeon in the body, think Fantastic Voyage. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Amazon introduced its much-anticipated home robot this week, and it's underwhelmed the robotics industry. Mike and Steve share their thoughts on why Astro's future doesn't look bright. Listeners also call in to share their thoughts on the home robot. We also sit down with Adam Sachs, CEO and founder of Vicarious Surgical. Adam discusses the company's next-gen surgical robotics system, the challenges and keys to building it, and debuting on the NYSE. https://www.vice.com/en/article/93ypp8/leaked-documents-amazon-astro-surveillance-robot-tracking

This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company's new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR's virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week's Newmarker's Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!

Our guest: Adam Sachs, Co-Founder & CEO at Vicarious Surgical "Vicarious Surgical is empowering surgeons with visionary robotics." In this episode, we discussed: His background Why-how-what of Vicarious Surgical What are some of the benefits of robotic surgery? How will robotic surgery play a role in the future of healthcare? Going public What's next? ...and much more! Our sponsors for this episode are BlocHealth, Curation Health, ChenMed & MediTelecare. BlocHealth is building the ecosystem of services and solutions to power the future of healthcare. For more information, please go to www.blochealth.com follow BlocHealth on social media - @blochealth "Curation Health's advanced clinical decision support platform seamlessly integrates into the electronic health record and leverages more than 750 proven clinical and quality rules. With this intelligent point-of-care platform, you can power a scalable risk adjustment process and amplify quality program performance." For more information, please go to www.curationhealthcare.com & follow Curation Health on social media - @curationhealth "ChenMed brings concierge-style medicine and better health outcomes to the neediest populations – moderate-to-low income seniors with complex chronic diseases. For more information, please go to www.chenmed.com & follow ChenMed on social media - @chenmed "MediTelecare provides behavioral telemedicine services to residents of skilled nursing and assisted living facilities, using state-of-the-art telehealth technology. For more information", please go to www.meditelecare.com & follow Meditelecare on social media – @meditelecare To learn more about Vicarious Surgical please use the links below: - Website - LinkedIn - Twitter - YouTube Also, be sure to follow Slice of Healthcare on our social channels: - Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Adam Sachs, co-founder and CEO of Vicarious Surgical, a company backed by Bill Gates and Vinod Khosla, discusses the company's Fantastic Voyage inspired-surgical robot that uses immersive reality to guide today's surgeons inside the body with new, groundbreaking technology that sets it apart from competitors. The system has received FDA Breakthrough Device designation. #VicariousSurgical #SurgicalRoboticsDisrupter Adam Sachs is CEO of Vicarious Surgical, a surgical robotics company he co-founded in 2014. Sachs leads the development and commercialization of the company's surgical robots to increase the efficiency of procedures and improve patient outcomes. Prior to founding Vicarious Surgical, Sachs worked at Apple in manufacturing. He holds a Bachelor of Science in mechanical engineering from MIT and has worked for more than 11 years as a volunteer emergency medical technician for MIT EMS, an ambulance serving the MIT community.

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history. Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage. Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care. Subscribe to this podcast on every major podcast channel!

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed. Subscribe to this podcast today on all major podcast channels.

Please join your favorite SPAC corporate attorneys, Tom Burton, Sahir Surmeli, and Jeff Schultz as they set the record straight on SPACs’ apparent boom and bust, heavily reported on in the media. In this episode, they will address the few reasons why SPAC transactions have slowed down, including the SEC’s heightened scrutiny, the question over company valuations, and recent market shifts. They will also explore the advantages now present in this new SPAC era. The Mintz team has handled numerous multibillion-dollar SPAC transactions in recent months, including for XL Fleet and Butterfly Network, as well as the recently announced deals involving Quantum-SI, DeepGreen Metals, and Vicarious Surgical. Mintz’s SPAC practice draws from decades of experience guiding clients in a broad spectrum of industries through the intricacies of SPAC financings. The firm handled the first New York Stock Exchange SPAC transaction and has completed over 35 SPAC transactions, including SPAC IPOs and de-SPAC mergers.

Adam Sachs is the Co-Founder and CEO of Vicarious Surgical a next generation robotics company that is developing a disruptive medical technology platform. Their goal is to increase the efficiency of legacy surgical robotics, improving patient outcomes and reducing healthcare costs.  Vicarious Surgical's novel approach to surgery uses a combination of proprietary miniaturized surgical robots and virtual reality to transport surgeons inside the patient when performing minimally invasive surgery. The first indication being targeted is ventral hernia repair for which Vicarious has been granted Breakthrough Device Special designation from the FDA. The Vicarious system, with nine-degrees of freedom for each arm of the robot, can actually operate from inside of the abdomen out. Surgeons are enthusiastic about the ability to work facing any direction from any incision site. #VicariousSurgery #VR #VirtualReality #robots #surgicalrobotics #herniarepair #ventralherniarepair #SPAC VicariousSurgery.com Download the transcript here

Adam Sachs is the Co-Founder and CEO of Vicarious Surgical a next generation robotics company that is developing a disruptive medical technology platform. Their goal is to increase the efficiency of legacy surgical robotics, improving patient outcomes and reducing healthcare costs.  Vicarious Surgical's novel approach to surgery uses a combination of proprietary miniaturized surgical robots and virtual reality to transport surgeons inside the patient when performing minimally invasive surgery. The first indication being targeted is ventral hernia repair for which Vicarious has been granted Breakthrough Device Special designation from the FDA. The Vicarious system, with nine-degrees of freedom for each arm of the robot, can actually operate from inside of the abdomen out. Surgeons are enthusiastic about the ability to work facing any direction from any incision site. #VicariousSurgery #VR #VirtualReality #robots #surgicalrobotics #herniarepair #ventralherniarepair #SPAC VicariousSurgery.com Listen to the podcast here

Emma Plouffe is the VP of People & Culture at Vicarious Surgical. Vicarious Surgical is a Surgical Robotics company that has experienced rapid growth over the past several years. Emma leads the People team with a strong passion for creating employee development programs, championing internal mobility and maintaining a great company culture. Her current focus is on expanding recruiting operations as the company is looking to again double in size over the next 12 months. Prior to her time at Vicarious Surgical, Emma spent 3 years leading the People Team at Markforged and helping the company scale from 70 to 300+ employees globally. She has been involved in leading all aspects of HR including talent development, compensation & benefits, talent acquisition, and executive coaching.  

Brian Feroldi brings another innovative healthcare company to the show -- Vicarious Surgical. The robotic surgery company will come public via a SPAC with D8 Holdings, we talk through the robotic surgery market, how the company's planned technology stacks up to the business that created the space, Intuitive Surgical, and what investors need to keep in mind with investing in pre-revenue businesses. Stocks: ISRG, DEH Check out more of our content here: Podcasts Youtube Twitter Reach us by Email @ IndustryFocus@fool.com

It seems that everyone is taking a second look at SPACs as the number of lawsuits against these alternative IPOs continues to increase by the day. The SEC has recently commented on the liability risks of SPACs under the securities laws following the agency’s heightened scrutiny of these blank-check companies. What exactly is happening, and how can SPAC actors mitigate the ever-increasing risk of litigation? This latest episode of SPAC Chat features your two favorite corporate attorneys in the forefront of SPACs, Jeff Schultz and Sahir Surmeli, along with two of Mintz’s leading litigators, Doug Baumstein and Sean Prosser, as they discuss this latest SPAC trend. The Mintz team has handled numerous multibillion-dollar SPAC transactions in recent months, including for XL Fleet and Butterfly Network, as well as the recently announced deals involving Quantum-SI, DeepGreen Metals, and Vicarious Surgical. Mintz’s SPAC practice draws from decades of experience guiding clients in a broad spectrum of industries through the intricacies of SPAC financings. The firm handled the first New York Stock Exchange SPAC transaction and has completed over 35 SPAC transactions, including SPAC IPOs and de-SPAC mergers.

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.

You'd never guess that this high energy people person who has been on the ground floor and helped shape, grow and hire several teams of brilliant engineers loves to hang on the couch and read with her 78 pound Black Mouth Cur named Mis Dos who hails from Georgia.  Ann recounts her adventures in start-ups, including her hopes for her newest role. During our conversation she touches on nurturing people, communicating with leadership teams, her words of balance and her thoughts on leadership-it's not about power. Her career path went from fashion and expanded into administration and communications, higher ed and being a women in the early days of robotics will keep you engaged and wanting more. Join us for our podcast with Ann Whittaker.